November 5, 2017, after months of intense preparation, Hopstem Biotechnology Co., Ltd. opened and inaugurated its new site in Hangzhou Zhongzi Economic and Technological Development Park. This is the first high-tech start-up company in China that focuses on iPSCs and neural stem cell storage and differentiation services. In line with the strategic needs of national biomedical innovation, it provides the most comprehensive and advanced frontier technologies for the research and treatment of neurological diseases in China.